Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 29, 2015, to report its financial results for the first quarter ended March 31, 2015. The primary purpose of this filing is to provide investors with a press release detailing the company's operational and financial performance during the quarter. While the 8-K itself does not contain detailed financial statements, it incorporates by reference a press release (Exhibit 99.1) which serves as the source for the company's first-quarter performance metrics. Investors should note that this filing primarily serves as a notification mechanism for the release of quarterly earnings information. The actual substance of the financial results, including key performance indicators, revenue, earnings per share, and any forward-looking statements or management commentary, would be found within the furnished press release. The disclaimer within the 8-K clarifies that the information furnished is not deemed 'filed' for certain legal purposes, emphasizing that the press release itself is the key document for reviewing the detailed financial outcomes of the first quarter of 2015.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) announced its first-quarter 2015 financial results on April 29, 2015.
- 2The 8-K filing serves to officially report these results to the SEC, primarily through an attached press release (Exhibit 99.1).
- 3The company's principal executive offices are located at 120 Monument Circle, Indianapolis, IN.
- 4The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
- 5Information furnished in this 8-K and its exhibits is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability for forward-looking statements within the press release.
- 6The press release contains the detailed financial performance for the quarter ended March 31, 2015.